Quality of Pharmaceutical Industry Press Releases Based on Original Research
Author Information
Author(s): Kuriya Bindee, Schneid Elana C., Bell Chaim M.
Primary Institution: University of Toronto
Hypothesis
The study aimed to systematically examine the quality of pharmaceutical company press releases about original research.
Conclusion
Pharmaceutical company press releases frequently report basic study details, but often lack important limitations and may mislead readers about the validity of results.
Supporting Evidence
- 59% of press releases reported results presented at scientific meetings.
- 76% of releases cited harms or adverse events.
- Only 6% of releases noted study limitations.
- 29% of releases did not quantify study results.
Takeaway
Pharmaceutical companies often share press releases about their research, but these can be misleading because they don't always include important details about the studies.
Methodology
The study evaluated 1028 press releases from the top 10 pharmaceutical companies in 2005, focusing on those based on original research.
Potential Biases
The press releases may be biased due to the profit-driven nature of pharmaceutical companies.
Limitations
The study only examined press releases from 2005 and did not verify the accuracy of the content against published studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website